Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03292289
Other study ID # QUALIPRO-1703
Secondary ID 2017-A01406-47
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 16, 2018
Est. completion date July 2024

Study information

Verified date June 2024
Source Centre Oscar Lambret
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a prospective, monocentric study whose aim is to assess the quality of life for patients who underwent a coloanal continuity reconstruction and to understand the functional issues they encounter. This will potentially provide predictive factors identification of bad functional outcomes allowing to guide future decisions. Also, it will allow patients to have a reinforced follow-up during the year after the reconstruction.


Description:

First of all, an information document will be given to the patients and their consent will be collected. Then, they will be registered through the online eCRF (or by FAX) and a study number will be given to each patient. The study will proceed with 2 stomatherapy consultations at one and six months after coloanal continuity reconstruction. Patient care and following up will proceed as usual. The stomatherapy consultation will be done by a qualified nurse. Before the 1st intervention (proctectomy): - Collect of clinical data and disease history - Quality of life questionnaires (EORTC-QLQ-C30 and CR29) - Evaluation of LARS score After the 1st intervention (proctectomy, at month 1): - Quality of life : EORTC-QLC30 and CR-29 questionnaires and Stom-QoL Before the 2nd intervention (coloanal continuity reconstruction): - Quality of life : EORTC-QLC30 and CR-29 questionnaires and Stom-QoL After the 2nd intervention (at month 1, month 3, month 6 and one year): - at 1 and 6 months : clinical exam (stomatherapy consultation) for collect of postoperative complications - Quality of life : EORTC-QLC30 and CR-29 questionnaires and LARS score


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 65
Est. completion date July 2024
Est. primary completion date July 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - 18 to 70 years old - Patients who are going to undergo a proctectomy for a rectal cancer (situated at a distance equal or lower to 15 cm from the anoderm) following by a coloanal continuity reconstruction (using direct, latero-terminal or colonic J-pouch anastomosis) - Already underwent or not a neoadjuvant radio-chemotherapy - Affiliation to the National Social Security System - With informed and signed consent Exclusion Criteria: - Unwilling patients - Patient deprived of their liberty or under guardianship or tutorship. - Abdominal perineal amputation - No stoma placement planned - Tumor more than 15 cm from the anal margin

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Pre- and post-operative consultation
Before and between the two interventions
Stomatherapy consultation
Clinical exam. At one and six months after the 2nd intervention
Questionnaires
QLQ-C30 and QLQ-CR29 at each time defined by the study (one month before and after the first intervention, before the 2nd intervention and at 1, 3, 6 and 12 months after the 2nd intervention) Stoma-QoL before and after the 2nd intervention LARS score at 1, 3, 6 and 12 months after the 2nd intervention

Locations

Country Name City State
France Centre Oscar Lambret Lille

Sponsors (3)

Lead Sponsor Collaborator
Centre Oscar Lambret Groupement Interrégional de Recherche Clinique et d'Innovation, Santelys Association

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of life 1 year after the second intervention, using LARS score Obtain an objective assessment of symptoms intensity (using the LARS score)for patients who received a proctectomy for rectal cancer ("1st intervention") following by a coloanal continuity reconstruction ("2nd intervention") from baseline to 1 year after the second intervention
Secondary Quality of life before the first intervention and after the second intervention Obtain an objective assessment of symptoms intensity (using the LARS score)for patients who received a proctectomy for rectal cancer ("1st intervention") following by a coloanal continuity reconstruction ("2nd intervention") from baseline to one year after the 2nd intervention
Secondary Quality of life using EORTC-QLQ-C30 Assess the quality of life using EORTC-QLQ-C30 questionnaires before the first intervention, between the first and the second intervention and after the second intervention from baseline to one year after the 2nd intervention
Secondary Quality of life using EORTC-QLQ-CR29 questionnaires Assess the quality of life using EORTC-QLQ- CR29 questionnaires before the first intervention, between the first and the second intervention and after the second intervention from baseline to one year after the 2nd intervention
Secondary Impact of stomy on quality of life Assess the impact of stomy on quality of life for patients who received a proctectomy for rectal cancer and using Stoma-QoL questionnaire from the first intervention to 6 months after the first intervention
Secondary Rate of patients with anastomotic fistula Determinate the rate of patients with anastomotic fistula requiring the conservation of the stomy, and so they cannot undergo a coloanal continuity reconstruction from the first intervention to 6 months after the first intervention
Secondary Surgical complications description Describe surgical complications linked to the coloanal continuity reconstruction from first intervention to one year after the 2nd intervention
Secondary Quality of life of patients with a second stoma placement, using EORTC-QLQ-CR29 questionnaires Assess the quality of life of patients who have a new stoma for functional disorder after restoration of digestive continuity . From the 2nd intervention to one year after the 2nd intervention
Secondary Quality of life of patients with a second stoma placement, using EORTC-QLQ-C30 questionnaires Assess the quality of life of patients who have a new stoma for functional disorder after restoration of digestive continuity . From the 2nd intervention to one year after the 2nd intervention
Secondary Quality of life of patients with a second stoma placement, using LARS score Assess the quality of life of patients who have a new stoma for functional disorder after restoration of digestive continuity . From the 2nd intervention to one year after the 2nd intervention
See also
  Status Clinical Trial Phase
Recruiting NCT06380101 - Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC) N/A
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Recruiting NCT04323722 - Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT04088955 - A Digimed Oncology PharmacoTherapy Registry
Active, not recruiting NCT01347697 - Collagen Implant (Biological Mesh) Versus GM Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer N/A
Recruiting NCT04495088 - Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer Phase 3
Withdrawn NCT03007771 - Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia Phase 1
Terminated NCT01347645 - Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer Phase 1/Phase 2
Not yet recruiting NCT03520088 - PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS N/A
Recruiting NCT05556473 - F-Tryptophan PET/CT in Human Cancers Phase 1
Recruiting NCT04749381 - The Role of TCM on ERAS of Rectal Cancer Patients Phase 2
Enrolling by invitation NCT05028192 - Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
Recruiting NCT03283540 - Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
Completed NCT04534309 - Behavioral Weight Loss Program for Cancer Survivors in Maryland N/A
Recruiting NCT05914766 - An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer N/A
Recruiting NCT04852653 - A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
Recruiting NCT03190941 - Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Phase 1/Phase 2
Completed NCT02810652 - Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection N/A
Terminated NCT02933944 - Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer Phase 1